Ligand-activated insulin receptor (IR) attracts and phosphorylates various substrates such as insulin receptor substrates 1-4 (IRS) and Shc. To investigate how binding affinity for substrate affects signalling we generated chimeric receptors with the β-chain of the insulin receptor containing NPXY motives with different affinities for receptor substrates. We found that the extent of receptor tyrosine phosphorylation positively correlates with binding affinity towards IRS1/2 but not towards Shc. Moreover, overexpression of IRS1 or IRS2 but not of Shc increased IR tyrosine phosphorylation in a dose-dependent manner, also independent of insulin. Molecular truncations of IRS1 revealed that neither the isolated PH and PTB domains nor the C-terminus with the tyrosine phosphorylation sites alone are sufficient for substrate-dependent receptor activation. Overexpression of IRS1 and IRS2 impaired insulin-induced internalization of the IR in a dose-dependent manner suggesting that IRS proteins prevent endosome-associated receptor dephosphorylation/inactivation. IRS1 and IRS2 could therefore target the activated IR to different cellular compartments. Overexpression of IRS1 and IRS2 inhibited insulin-stimulated activation of the MAP kinases Erk1/2 while it increased/induced activation of Akt/PKB. Finally, overexpression of IRS1 and IRS2 but not of Shc induced DNA synthesis in starved CHO-IR cells independent of exogenous growth factors. Our results demonstrate that variations in cellular IRS1 and IRS2 concentration affect insulin signalling both upstream and downstream and that IRS proteins could play instructive rather than just permissive roles in signal transmission.
Introduction
Insulin action (reviewed by [1] ) depends on the activation of the insulin receptor (IR), a tetrameric transmembrane tyrosine kinase (RTK) consisting of two extracellular α-and two intracellular β-subunits with the RTK residing on the β-subunits. Binding of insulin to the α-subunits results in rapid autophosphorylation of several tyrosine residues in the E X P E R I M E N T A L C E L L R E S E A R C H 3 1 3 ( 2 0 0 7 ) 8 0 5 -8 1 5 intracellular part of the receptor [2, 3] . The autophosphorylation sites are clustered in three regions. Two sites reside within the juxtamembrane region, three within the regulatory loop of the kinase and two within the COOH-terminal tail. The tyrosine clusters have different roles in the propagation of the insulin signal: First, phosphorylation of the regulatory loop is required for full activation of the RTK. The activated kinase then phosphorylates the tyrosine residue within the sequence NPEY located in the juxtamembrane region. This NPEY motif is a variation of the consensus binding site (NPXY) for phosphotyrosine binding (PTB) domain-containing proteins. Once phosphorylated it attracts receptor substrates which contain a PTB domain, like the insulin receptor substrate (IRS) proteins and Shc [4] . In addition to the recruitment of receptor substrates, phosphorylation of the NPEY motif in the juxtamembrane region of the IR is required for insulin-induced receptor endocytosis [5] . The role of the third tyrosine cluster in the COOH-terminal tail of the IR is not fully understood but it seems to be required for fine-tuning of the kinase activity [6] , and eventually recruits signalling components with SH2 domains such as Grb10 [7] .
Besides the IR, also the activated interleukin-4 (IL-4) receptor recruits IRS proteins via a NPXY (NPAY) motif. This raises the question of how these different receptors can transmit specific signals through the same receptor substrates. Previous work suggests that the NPAY motif found in the IL-4 receptor binds the PTB domain of IRS1 about 30 times stronger compared to the NPEY motif of the IR [8, 9] .
Two major pathways are activated downstream of insulin receptor substrates: Grb2 induces the MAP kinase cascade resulting in the activation of Erk1 and Erk2 (p42/p44) through phosphorylation of threonine 202 and tyrosine 204 [10, 11] . The regulatory subunit (p85) of PI 3′ kinase (PI3K) stimulates the synthesis of PI3,4,5P3 and finally leads to activation of the serine-threonine kinase Akt/PKB. Akt activation requires phosphorylation of threonine 308 and serine 473 [12] .
We hypothesized that the steady-state level of the receptor-substrate complex could influence signal propagation. In this study we show that modulating the affinity between receptor and substrates affects the phosphorylation state of both, the receptor and its substrate. In addition we present evidence that overexpression of IRS1 and IRS2, but not of Shc can mimic insulin action in CHO-IR cells which might in part depend on the inhibition of receptor-endocytosis.
Experimental procedures

Reagents and antibodies
Chemicals were purchased from SIGMA (Buchs, Switzerland) unless otherwise mentioned. Human recombinant M-CSF was obtained from Calbiochem (JURO, Lucerne, Switzerland), bovine insulin from SIGMA and [ 125 I]-insulin from Amersham Pharmacia (Dübendorf, Switzerland). Antibodies against phosphotyrosine (PY99), the insulin receptor β-subunit, IRS1, IRS2, Shc and Rabbit anti-Grb2 (C-23) were purchased from Santa Cruz Biotechnology Inc. Antibodies against phospho-Akt, phospho-Erk1/2 and p85 were obtained from Cell Signaling (Beverly, USA).
Cell culture and treatments
Cell culture media and other reagents were purchased from Gibco BRL. HEK 293 cells and CHO-K1 cells were a gift of the Department for Calcium Metabolism, Zurich. They were grown in DMEM supplemented with 10% FBS (HEK 293 cells) or HAM F12 supplemented with 10% FBS (CHO K1 cells). CHO-IR cells were a gift of Jeffery E. Pessin (Iowa City, USA) and were grown in HAM F12 supplemented with 10% FBS. All cells were grown at 37°C and 5% CO 2 , and in the presence of 100 U/ml penicillin and 100 μg/ml streptomycin (Gibco BRL).
Cells were transfected with plasmid DNA in 6-or 24-well plates after they reached 80-90% confluence using Lipofectamine 2000 (Gibco BRL). CHO-K1 cells were harvested 24 h and HEK 293 cells 48 h post transfection for further analysis.
Plasmids and adenoviral vectors
We generated the CSF/IR chimeric receptor as described by Chaika et al. [13] . After subcloning into the expression vector pCMV, transfer mutations were introduced into the isolated Bsu36 I-Xho I fragment of the CSF/IR chimeric receptor by polymerase chain reactions. The cDNA of the human insulin receptor was subcloned into pcDNA3.1 (Invitrogen, Groningen, The Netherlands). The expression constructs encoding human Shc, human IRS1, and mouse IRS2 have been described previously [14] .
Co-immunoprecipitation, Ni-NTA purification and Western blotting HEK 293 cells were transfected in 6-well plates with a plasmid mixture containing 1.25 μg of expression vector coding for myc-tagged IRS1, IRS2 or Shc, respectively and additionally 1.25 μg of plasmid either encoding a respective mutant chimeric receptor or GFP. 44 h post transfection, cells were serum-deprived for 4 h in DMEM containing 0.5% BSA and subsequently stimulated for 10 min with 10 nM M-CSF. Thereafter, cells were lysed in lysis buffer (20 mM Tris, pH 7.5, 100 mM NaF, 1% NP-40, 5 mM EDTA) freshly supplemented with 1 mM PMSF, 3 mg/ml aprotinin, 3 mg/ml leupeptin, 1 mM Na 2 H 2 P 2 O 7 , and 1 mM Na 3 O 4 V. Precleared lysates were incubated with 0.5 μg of α-insulin receptor β-chain antibody for 1 h at 4°C under constant shaking. 20 μl of immobilized protein A on trisacryl (Pierce, Rockford, USA), equilibrated in lysis buffer were added to the cell lysates and equilibrated over night at 4°C on a rotating wheel. Thereafter beads were collected by a short centrifugation and washed 3 times with cold PBS. Finally, 20 μl of 1.5× SDS gel loading buffer (75 mM Tris/ HCl, pH 6.8, 3% SDS, 15% glycerol, 0.15% bromophenol blue, 7.5% 2-mercaptoethanol) were added, samples were boiled for 3 min and beads were removed by short centrifugation. Supernatants were separated on SDS-PAGE.
For pull-down experiments with Ni-NTA CHO-IR cells were grown on 10 cm plates and infected with adenoviral vectors encoding myc-HIS-tagged IRS1, IRS2, Shc or GFP as a control. After 48 h, cells were washed with PBS and starved in appropriate medium as described for HEK293 cells. If required insulin was added for 4 min followed by 3 washes with ice-cold PBS. Cells were lysed in 100 mM HEPES, 0.5% Triton X-100, 150 mM NaCl in the presence of protease and phosphatase inhibitors. Affinity purification of HIS-tagged IRS1, IRS2 and Shc using Ni-Agarose (Ni-NTA) was essentially as described by the manufacturer (Qiagen). After elution with 300 mM imidazol proteins were separated by SDS-PAGE. 
Results
Receptors with different variations of the juxtamembrane NPXY motif are differentially tyrosine phosphorylated
We introduced mutations into the NPEY motif within the insulin receptor to modulate its affinity for IRS-proteins, and studied how this modulation affects signal transduction. To exclude ligand-specific effects and in order to distinguish mutated receptors from endogenous insulin receptors we generated chimeric receptors consisting of the extracellular domain of the CSF-1 receptor and the intracellular portion of the insulin receptor (CSF/IR) [13] . Exposure of transfected cells to M-CSF dose-dependently increased autophosphorylation of chimeric receptors (data not shown). Chimeric receptors with the following NPXY (PTB domain-binding) motifs were generated: i) NPEY, as found in the insulin receptor; ii) NPEF, which cannot be phosphorylated and hence eliminates phosphorylation-induced binding of the PTB domain [2, 8] ; iii) NPAY, corresponding to the motif found in the IL-4 receptor, which binds the IRS1 PTB domain 30-fold stronger compared to the NPEY motif; and iv) APEY, that exhibits no binding in a peptide binding assay [9] . To confirm the previously described effects of these different mutations on complex formation between chimeric receptor and IRS proteins, we tested the receptor-substrate interactions by coimmunoprecipitations. The CSF/IR chimeric receptors were coexpressed with constant amounts of myc-tagged IRS1 in 293 cells. After stimulation with 10 nM M-CSF for 10 min, cells were lysed and chimeric receptors were immunoprecipitated with an antibody recognizing the β-chain of the insulin receptor.
The amount of co-precipitated IRS1 was assessed by immunoblotting with an antibody against the myc tag. As shown in Fig. 1A , in the absence of chimeric receptors, no myc-tagged IRS1 could be co-precipitated with the antibody against the insulin β-chain. Together with the receptor containing the NPEY motif considerable amounts of IRS1 were co-precipitated in the absence of extracellular ligand. Co-precipitation of IRS1 was increased 2-3 times after stimulating cells with M-CSF. Different results were obtained with chimeric receptors containing the NPEF motif. In the absence of M-CSF coprecipitation of IRS1 was similar to levels observed with NPEY-containing receptors. However, exposure of cells to M-CSF did not increase co-precipitation of IRS1. In contrast, receptors containing NPAY co-precipitated around 4 times more IRS1 in the absence and 2 times more in the presence of M-CSF compared to receptors containing the NPEY motive, respectively. Almost no IRS1 was co-precipitated with receptors containing the APEY motif, independent of stimulation with M-CSF. These results correspond well with the previously determined relative affinities of peptides with respective NPXY motives towards the PTB domain in vitro [9] . In the course of the above experiments we noticed that the degree of tyrosine phosphorylation ( stimulation, but also with affinity for IRS1. Receptors containing a high affinity-binding motif such as NPAY, and NPEY revealed a more pronounced tyrosine phosphorylation than receptors with a low affinity binding motif (APEY, NPEF), remarkably, even in the absence of ligand stimulation. A quantification of the results is shown in Fig. 1B .
Overexpression of IRS1 and IRS2 but not of Shc increases insulin receptor tyrosine phosphorylation in a dose-dependent manner
Because our results suggested that increasing the affinity between receptor and substrate can augment receptor phosphorylation independent of the presence of the extracellular ligand we tested whether receptor phosphorylation was proportional to increasing concentrations of substrates. For this purpose a constant amount of plasmid coding for the wild type insulin receptor was co-transfected into CHO-K1 cells with increasing amounts of plasmid encoding IRS1, IRS2, or Shc. Cells were lysed, and the amount of tyrosine phosphorylated protein was evaluated by Western blotting using antibodies against phosphotyrosine residues ( Fig. 2A) . The expression level of the exogenous insulin receptor was kept constant in all transfectants whereas the level of the receptor substrates IRS1, IRS2 and Shc increased dependent on the transfected amount of corresponding expression plasmids (Fig. 2B) . The results shown in Fig. 2A demonstrate that the extent of insulin receptor tyrosine phosphorylation in the absence and in the presence of 100 nM insulin increased with increasing levels of IRS1. This induction of receptor phosphorylation by its substrate was significant as it even exceeded receptor tyrosine phosphorylation after exposure to 100 nM insulin in the absence of exogenous IRS1. While IRS2 induced receptor phosphorylation similar to IRS1 ( Fig. 2A) , no dose-dependent increase but rather a decrease in insulin receptor tyrosine phosphorylation was detected if Shc was overexpressed ( Fig. 2A) , although the cellular content of Shc was substantially increased in transfectants (Fig. 2B) . Shc was strongly tyrosine phosphorylated ( Fig. 2A) which suggests that the ectopically expressed protein was functional. 
The role of the various domains of IRS1 in insulin receptor tyrosine phosphorylation
In order to determine the essential domains of IRS1 that are required for the stimulatory effect on the IR we co-expressed myc-tagged truncations of IRS1 and the full-length IR in CHO-K1 cells. The various fragments of IRS1 used for this experiment are shown in Fig. 3A . Immunoblotting with a myc-specific antibody showed that the truncations were expressed to the same level as full-length IRS1-myc (Figs. 3B  and C, lower panel) . The expression of exogenous insulin receptor remained constant in all transfectants (middle panel). Neither IRS1(C-term) nor IRS1(PH-PTB) stimulated receptor tyrosine phosphorylation, although IRS1(C-term) was tyrosine phosphorylated at high expression levels (Fig.  3C, top panel) . Moreover, at high expression levels IRS1(PH-PTB) repressed insulin-induced tyrosine phosphorylation of the IR β-chain. IRS1(ΔPH) was strongly tyrosine phosphorylated at high expression levels, comparable to full-length IRS1 (Fig. 3B) . However, exposure of the cells to 100 nM insulin only marginally further increased substrate tyrosine phosphorylation. IRS1(ΔPH) augmented insulin receptor tyrosine phosphorylation but to a lesser extent than fulllength IRS1 (Fig. 3B) . Finally, also overexpressed IRS1(ΔPTB) was significantly tyrosine phosphorylated, but to a lesser extent than IRS1(ΔPH). In addition, deletion of the PTB domain reduced the stimulation of receptor tyrosine phosphorylation more pronounced than deletion of the PH domain (Fig. 3B) .
Overexpression of IRS1 and IRS2 decreases the rate of insulin receptor endocytosis (α pY, upper panel) . Expression of the insulin receptor was assessed using an antibody against the β-chain of the insulin receptor (lower panel).
shown). As shown in Fig. 4A , infection with control virus encoding GFP did not alter the internalization rate of insulin compared to uninfected cells. However, overexpression of IRS1 and of IRS2 resulted in a significant and dosedependent decrease in the internalization rate. Shc had a much weaker effect on receptor internalization even though its expression levels were high (Fig. 4A, right panel) . The cellular content of insulin receptor was not affected by adenoviral overexpression of GFP, IRS1, IRS2, and Shc (data not shown).
To test if decreased receptor endocytosis per se could increase receptor tyrosine phosphorylation, we inhibited cellular endocytosis by hyperosmolar sucrose [15] [16] [17] and assessed tyrosine phosphorylation of the insulin receptor. 0.4 M sucrose reduced receptor endocytosis more than 6-fold (Fig. 4A) . Serum-deprived CHO-IR cells were incubated with 10 nM insulin for 0 to 30 min and equal amounts of cell lysates were analysed on Western blots (Fig. 4B) . At all time points insulin caused a pronounced increase in receptor tyrosine phosphorylation. Pre-treatment with 0.4 M sucrose alone was not sufficient to induce tyrosine phosphorylation of the IR but sucrose synergistically increased phosphorylation of the IR in combination with insulin. As shown in the lower panel of Fig.  4 the expression levels of the IR were unaffected by sucrose treatment. The above experiments suggest that substrateinduced tyrosine phosphorylation of the insulin receptor could in parts dependent on decreased insulin receptor internalization but inhibition of internalization per se is not sufficient to activate the receptor.
Differential effects of IRS1, IRS2 and Shc on the activation of Akt/PKB and Erk1/2
In order to investigate if substrate-mediated receptor activation affects downstream signalling events we assessed the activation of Akt/PKB and Erk1/2. CHO-K1 cells were transiently co-transfected with constant amounts of expression plasmids encoding insulin receptor and myc-tagged IRS1, IRS2 and Shc, respectively. 20 h post transfection cells were serumdeprived for additional 4 h and then stimulated for 4 min with different concentrations of insulin as indicated prior to protein extraction for immunoblotting (Fig. 5A ) with specific antibodies against Akt/PKB phosphorylated at serine 473 and Erk1/2 phosphorylated at threonine 202 and tyrosine 204, respectively. Control experiments revealed that similar amounts of the insulin receptor were present in all cell lysates. Comparable amounts of the three insulin receptor substrates were detected in the lysates from cells that were transfected with corresponding vectors (data not shown).
The combination of insulin challenge and simultaneous overexpression of insulin receptor substrates revealed two phases with respect to Akt/PKB activation (Fig. 5A top lane) . Up to concentrations of 0.5 nM insulin, overexpression of IRS1 or IRS2 and hormonal stimulation synergistically increased the activation of Akt/PKB. IRS2 was slightly more potent than IRS1, although IRS2 was less abundant in the experiment shown (Fig. 5A, lane 4) . Upon stimulation with 2 or 10 nM insulin no additional increase in the phosphorylation of Akt/PKB was observed with overexpression of IRS1 or IRS2. In contrast to Overexpression of insulin receptor substrates affected the activation of Erk1/2 differently compared to the activation of Akt/PKB (Fig. 5, lane 2) . At low insulin concentrations (0.02 and 0.1 nM), overexpression of IRS1, IRS2 and Shc did not substantially alter the insulin-induced phosphorylation of Erk1/2. However, at higher hormone concentrations, IRS2 and to a smaller extent IRS1 inhibited activation of Erk1/2, whereas Shc showed no effect compared to control cells that were transfected with GFP.
Insulin-induced activation of Erk1/2 requires recruitment of Grb2 to receptor substrates while activation of Akt/PKB depends on p85, the regulatory subunit of PI3K. We affinitypurified ectopically expressed HIS-tagged IRS1, IRS2 and Shc from starved or insulin-stimulated CHO-IR cells using Ni-NTA. Eluates were then analysed by Western blotting with antibodies against Grb2 and p85 in order to test if they co-purify with receptor substrates. Results are presented in Fig. 5B . p85 co-purified with ectopically expressed IRS1 and IRS2 to the same extend from lysates of starved and insulin-stimulated CHO-IR cells. Co-purification of p85 was undistinguishable between Shc and GFP expressing cells, indicating that only very little or no p85 is bound to ectopically expressed Shc. Quantification of signal intensities shows that around 5-fold more p85 co-purified with IRS1/2 compared to Shc or GFP. Grb2 only co-purified with IRS1/2 and Shc when cells had been stimulated with insulin but not after starvation. About 2-3 times more Grb2 was bound to Shc than to IRS1/2. Similar results were obtained with immunoprecipitation experiments (not shown).
Overexpression of IRS1 and IRS2 but not of Shc induces proliferation in CHO-IR cells
In a last series of experiments we assessed insulin-dependent proliferation in CHO-IR cells by measuring [ 3 H]-thymidine incorporation after overexpression of insulin receptor substrates. Fig. 6 A summarizes our results after overexpression of IRS1, IRS2 or Shc. In five independent experiments overexpression of IRS1 and IRS2 but not of Shc induced DNA replication independent of insulin. The levels of ectopic expression were similar for all receptor substrates (not shown). At insulin concentrations of 0.5 and 5 nM both IRS1 and IRS2 enhanced proliferation synergistically with hormone. At 50 nM insulin the proliferation rate was already maximal and could hence not be further enhanced by overexpression of IRS1/2. In contrast, Shc slightly repressed insulin-induced [ 3 H]-thymidine incorporation. Immunoblots confirmed that adenovirus-based overexpression of IRS1 and IRS2 but not of Shc induced/increased the activation of Akt/ PKB as in our previous experiments described above after transfection of plasmid DNA using lipofectamine.
To further delineate the mitogenic effect of IRS proteins, subfragments of IRS1 were transfected into CHO-IR cells (Fig.  6B) . Overexpression of the PH-PTB domain alone repressed basal and insulin (5 nM)-induced [ 3 H]-thymidine incorporation significantly while all other fragments did not significantly differ from GFP, indicating that the former fragment interferes with the stimulatory effect of full-length IRS proteins by competing for the receptor binding. To test this hypothesis GFP or full-length IRS1 was simultaneously overexpressed together with the PH-PTB or the C-terminal fragment of IRS1 (C-term). Results are shown in Fig. 6C . As in previous experiments full-length IRS1 but neither GFP nor the C-terminal fragment of IRS1 stimulated thymidine incorporation at 0 and 5 nM insulin. The PH-PTB domain inhibited DNA replication in the absence and presence of insulin. In addition it competed with the stimulatory effect of full-length IRS1 and reduced its potential to enhance thymidine incorporation. Interestingly, although the C-terminal fragment by itself did not affect thymidine incorporation it diminished the stimulation by full-length IRS1, presumably by competing with fulllength IRS1 for downstream signalling components.
Discussion
Insulin receptor substrates are usually viewed as unidirectional signal transmitters that receive stimuli from upstream receptors and forward them to downstream effectors. Our results now suggest that IRS1 and IRS2, but not Shc, can also send information upstream to the receptor. IRS1 and IRS2 can activate the IR independent of prior hormonal stimulation and they are able to potentiate insulin-dependent activation.
In response to CSF-1 CSF-1/IRβ chimeric receptors that contained modified binding motifs (NPXY) for the PTB domain in insulin receptor substrates were tyrosine phosphorylated depending on binding affinity for their substrates. Receptors with the high affinity binding motif NPAY were hyperphosphorylated compared to receptors with the low affinity NPEY motif. Hence high affinity binding of IRS proteins to the receptor enhances its tyrosine phosphorylation. Our observations were not restricted to CSF/IR chimeric receptors. Chimeric receptors consisting of the extracellular domain of the EGF receptor and the intracellular domain of the insulin receptor [18] containing the same mutations within the NPXY motif showed similar results (data not shown).
We also demonstrate that the tyrosine phosphorylation state of the insulin receptor correlates with the cellular concentration of IRS1 and IRS2. Since insulin receptor activity is directly proportional to the extent of its tyrosine phosphorylation [19] we can conclude that the receptor substrates do not only passively forward signalling information but that they can directly augment receptor kinase activity and thereby probably intensify signal transduction. However, not every substrate that interacts with the NPXY motif in the intracellular domain of the insulin receptor is also able to control receptor activity. Although Shc was overexpressed at similar levels compared to IRS1/2 it failed to affect receptor tyrosine phosphorylation. Because the ectopically expressed Shc protein was tyrosine phosphorylated it probably served as an insulin receptor substrate, as indicated by its tyrosine phosphorylation ( Fig. 2A) and we therefore conclude that it was functional. In contrast, at high expression levels, IRS1 and IRS2 stimulated insulin receptor tyrosine phosphorylation to a similar extent as stimulation with the ligand insulin. Such insulin-independent but substrate-induced activation of the IR kinase has to our knowledge not been reported before. However, Solow and co-workers [20] described previously that IRS1 but not IRS2 can increase insulin-induced tyrosine phosphorylation of the IR in 32B cells.
Our findings raise the question about the mechanism by which receptor substrates that lack enzymatic activity enhance tyrosine phosphorylation of transmembrane receptors, and secondly, if substrate-initiated receptor activation induces similar downstream signalling events as extracellular ligand-dependent activation. Insulin activates Erk1/2 and to a lesser extend Akt/PKB in CHO-IR cells. In contrast, overexpression of IRS1 or IRS2 activated Akt/PKB but repressed activation of Erk1/2. This observation strongly indicates that activation of the IR by insulin and IRS1/2 are not equivalent events. Indeed, our pull-down experiments with CHO-IR cells overexpressing receptor substrates (Fig. 5B) suggest that with or without insulin stimulation overexpressed IRS1 and IRS2 associate with PI3K (p85) to activate the Akt/PKB branch of signal transduction. Shc did not associate with p85 which is consistent with the finding that overexpression of Shc did not activate Akt/PKB. This observation is consistent with our finding that overexpression of IRS1 and IRS2 activates the IR similar to insulin stimulation. On the other hand, Grb2 which links insulin signalling to the Ras/ERK pathway only copurified with IRS1/2 and, more strongly, with Shc after stimulation with insulin. Higher affinity of Grb2 to Shc than to IRS1/2 suggests that Shc is normally recruited to activate ERK in CHO-IR cells downstream of insulin. Ectopically expressed IRS1/2 might therefore compete with Shc for binding to Grb2 and thereby interfere with insulin-induced activation of Erk1/2. As described previously, activation of Akt/ PKB can be mitogenic [21, 22] which is consistent with our observation that overexpression of IRS1 and IRS2 in CHO-IR cells increases proliferation (Fig. 6 ). It could therefore be that in our system the activation of Akt/PKB is epistatic to repression of activation of Erk1/2.
We show that IRS1 and IRS2 can prevent internalization of the IR (Fig. 4) and this might in part underlie substrate-induced receptor activation. Inhibition of internalization per se does, however, not trigger receptor activation, since incubation of cells with sucrose did not result in receptor phosphorylation. Receptor endocytosis and hence receptor compartmentalization are important for the termination of ligand-induced signalling but also for correct spatial organization of signal propagation [23] [24] [25] [26] . Dynamic compartmentalization and endosome-related dephosphorylation/inactivation of the receptor might be changed after overexpression of IRS1 and IRS2 and such substrate-triggered prolonged activity of the IR in specific cellular compartments might explain the difference in ligand versus substrate stimulation. Our finding is consistent with results obtained by Solow and co-workers [20] who suggested that IRS1 might increase tyrosine phosphorylation of the IR by inhibiting protein phosphatases.
To elucidate the molecular difference between IRS1/2 and Shc and to delineate the domains that are involved in receptor stimulation we used truncated forms of IRS1. Deletion of the PH or the PTB domain from IRS1 resulted in far weaker activation of the IR compared to full-length IRS1 (Fig. 3) . In addition, parts of the C-terminus of IRS1 are required that are beyond amino acid 517. This is in accordance with previous findings [20] showing requirement for tyrosine phosphorylation of sequences within the IRS1 Cterminus. Our observations extend that notion and indicate that the C-terminus alone without the PH-PTB domains is not sufficient and that a fragment of IRS1 only encompassing the PH-PTB domains without the C-terminus even represses insulin-induced phosphorylation of the IR (Fig. 3) . Although Shc has a PTB domain that is structurally and functionally similar to the PH and PTB domains of IRS [27, 28] and although it serves as target for tyrosine kinases Shc is unable to stimulate IR tyrosine phosphorylation in CHO cells. In contrast to IRS proteins Shc lacks an extended domain with multiple tyrosine phosphorylation sites. The decisive role of the extended C-terminus of IRS proteins in IR activation and its absence in Shc protein might explain why Shc is ineffective in stimulating tyrosine phosphorylation of the IR and to affect activation of Akt and Erk1/2.
The roles of the different parts of IRS1 were also evaluated in thymidine incorporation assays (Fig. 6) . Only full-length IRS1 and IRS2 but not Shc were able to enhance DNA synthesis in the absence or in the presence of insulin. As expected from its ability to bind to the IR, IRS1(PH-PTB) reduced the mitogenic effect of both, ectopically expressed full-length IRS1 and of insulin presumably by competing with full-length IRS for binding to the receptor. Surprisingly, although IRS1(C-term) is not expected to bind to the IR, because it lacks the N-terminal PH-PTB domains, this fragment also inhibited thymidine incorporation induced by overexpression of full-length IRS1 (Fig. 6C) and IRS2 (not shown). We found that this fragment was strongly tyrosine phosphorylated in the absence of insulin (Fig. 3C ) and it might hence attract phosphotyrosine binding proteins thereby competing with the correct spatial activation of effectors for DNA replication. The observation that the C-terminal fragment of IRS1 impairs IRS1-induced but not insulin-induced thymidine incorporation implies that the signalling cascades that are activated by the ligand or the substrate differ either in their composition or in spatial organization. This notion is further supported by results with other truncated IRS1 fragments. Expression of IRS1(1-571), IRS1(ΔPH) and IRS1 (ΔPTB) at the highest levels induced insulin-independent phosphorylation of the IR β-chain (Fig. 3) but, remarkably, these fragments did not induce proliferation, neither in the absence of nor synergistically with insulin. Therefore, activation of the IR appears to be required but not sufficient for mitogenicity, and probably interaction with full-length IRS proteins in a specific compartment is required.
The roles of IRS1 and IRS3 in cell cycle progression of CHO-IR cells has been studied previously by Kaburagi and coworkers [29] . These authors generated stable cell lines ectopically expressing either IRS1 or IRS3. Their major finding was that IRS3 antagonized insulin-induced cell cycle progression. IRS1 showed either no or only minor stimulatory effects. The fact that IRS1 had no major effect on proliferation might be explained by a rather low level of ectopic IRS1 in stable transfectants. The more pronounced effect of IRS1 (and IRS2) in our study might be explained by ectopic expression that greatly exceeded endogenous levels in transient transfectants (Fig. 2B) . Interestingly, and in support of our observations, IRS3, which lacks a major C-terminus in comparison to IRS1 and IRS2, did not stimulate but inhibited cell cycle progression probably because it competed with endogenous IRS1 and IRS2 for binding to the IR and thus interrupted its mitogenic signal transmission.
We had previously shown [14] that overexpression of IRS2 induces proliferation and represses apoptosis in pancreatic β-cells. Moreover, growth factors such as insulin, D-glucose and the incretin GLP-1 [30, 31] upregulate levels and phosphorylation state of IRS2 in β-cells. This is believed to be critical for maintenance and for a compensatory increase of functional β-cell mass to counteract insulin resistance. Interestingly, only overexpression of IRS2 but not of IRS1 or Shc increased proliferation in β-cells. This points to the importance of cellular context for the effect of the different members of the IRS family and thus might explain the discrepancy between the results presented here and previous results [14, 20] .
However, the effects of naturally occurring or experimentally induced variations in the cellular content of IRS proteins underline their importance in the regulation of cell proliferation and cellular function. Upregulation of IRS2 has been observed in metastatic variants of breast cancer cell lines [32] , in pancreatic cancers [33] , and recently in hepatocellular carcinoma [34] . Transgenic mice with targeted hepatic overexpression of IRS1 displayed increased liver size and glycogen content [35] , transgenic 2-fold increase in expression of IRS2 in murine B cells [35] , did not increase B cell proliferation, but altered Ig production. In light of our findings that high level expression of IRS proteins can trigger signal transduction independent of ligand-activated receptors, it appears likely that increased expression of IRS1/2 and maybe also IRS3/4 could play instructive rather than just permissive roles in the control of metabolism, cell growth, proliferation and apoptosis.
